Neonc Technologies Holdings (NTHI) Current Leases (2024 - 2026)

Neonc Technologies Holdings (NTHI) posted quarterly Current Leases of $72348.0 for Q1 2026, up 1.71% quarter-over-quarter from $71131.0 in Q4 2025.

Neonc Technologies Holdings (NTHI) Current Leases (2024 - 2026) Analysis & Trends

Neonc Technologies Holdings (NTHI) has reported Current Leases for 3 consecutive years, with $72348.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Current Leases changed N/A year-over-year to $72348.0; the TTM figure through Mar 2026 stood at $72348.0 (changed N/A YoY), while the FY2025 annual figure was $71131.0, up 187.72% from the prior year.
Current Leases rose to $72348.0 in Q1 2026 per NTHI's latest filing, from $71131.0 in the prior quarter.
Across five years, Current Leases topped out at $72348.0 in Q1 2026 and bottomed at $24722.0 in Q4 2024.
Historically, Current Leases has averaged $61342.2 across 3 years, with a median of $69877.0 in 2025.
On a YoY basis, Current Leases climbed as much as 187.72% in 2025 and fell as far as 187.72% in 2025.
Neonc Technologies Holdings' Current Leases stood at $24722.0 in 2024, then jumped by 187.72% to $71131.0 in 2025, then grew by 1.71% to $72348.0 in 2026.
Business Quant data shows NTHI's Current Leases at $72348.0 in Q1 2026, $71131.0 in Q4 2025, and $69877.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	720.00 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	21.95 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	45.93 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	6.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Neonc Technologies Holdings	116.41 Mn	116.41 Mn	-	73,669.00

Download Data